FIELD: medicine. SUBSTANCE: experimental procedures prescribes using the preparation - complex including mono-oligo-ribonucleotides - as means for curing ischemic lesion of encephalon. EFFECT: excellent drug for treating cerebral disorders of ischemic nature. 1 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR OPTIMIZATION OF ANTIAGGREGATIONAL THERAPY IN PATIENTS WITH CEREBROVASCULAR DISEASES | 2000 |
|
RU2188008C2 |
MEDICINAL COMPOSITION | 2001 |
|
RU2213562C2 |
PHARMACEUTICAL COMBINATION OF ATORVASTATIN AND NICERGOLIN FOR PREVENTING OR TREATING CEREBROVASCULAR DISEASE | 2011 |
|
RU2481124C1 |
METHOD OF TREATMENT OF PATIENTS WITH CENTRAL NEUROLOGICAL DISORDERS AT CEREBRAL CIRCULATION IMPAIRMENT AND CENTRAL NERVOUS SYSTEM TRAUMAS | 1996 |
|
RU2126689C1 |
MEDICINAL PREPARATION FOR CURING CEREBRAL ISCHEMIA | 1994 |
|
RU2108095C1 |
MEANS FOR TREATING ISCHEMIA OF VASCULAR BRAINS | 2016 |
|
RU2625740C1 |
PREPARATIONS OF ANTIHYPOXIC PROPERTIES | 2002 |
|
RU2232576C2 |
METHOD OF TREATING CEREBRAL CIRCULATION DISTURBANCES | 2009 |
|
RU2401096C1 |
MEDICINAL AGENT FOR PREVENTING AND TREATING CEREBRAL DISEASES AND METHOD OF TREATING CEREBRAL DISEASES | 2015 |
|
RU2692063C2 |
METHOD FOR TREATING DISTURBANCES OF CEREBRAL BLOOD CIRCULATION | 0 |
|
SU1734755A1 |
Authors
Dates
1994-07-30—Published
1990-09-12—Filed